# A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

> **NCT00130793** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 368 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation
- **BIOLOGICAL:** Comparator: zoster vaccine live (Oka/Merck) frozen formulation

## Key facts

- **NCT ID:** NCT00130793
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2015-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130793, "A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00130793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*